The Swiss pharmaceutical company Novartis is taking the Indian government to court over its national patent law. Novartis has been refused a patent for one of its medicines, Gleevec, on the grounds that the medicine is simply a new form of an old medicine with a trivial change, and cannot therefore be patented under Indian law.
Contact
Social Justice and Ecology Secretariat
Curia Generalizia della Compagnià di Gesù
Borgo Santo Spirito 4
00193 Roma – Italy
Tel. +39 06 698 68 393
Email [email protected]